Overview

A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status

Status:
Completed
Trial end date:
2019-03-31
Target enrollment:
Participant gender:
Summary
A clinical trial to investigate the appropriate dose of isoniazid according to NAT2 polymorphism status in Korean subjects
Phase:
N/A
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
Ministry of Health & Welfare, Korea
Treatments:
Isoniazid